StockNews.com Downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Hold
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Friday. Several other research firms also recently commented on ALNY. Chardan Capital restated a “buy” rating and set a $300.00 price objective on shares of Alnylam Pharmaceuticals […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Friday. Several other research firms also recently commented on ALNY. Chardan Capital restated a “buy” rating and set a $300.00 price objective on shares of Alnylam Pharmaceuticals […]
